Pathological Myopic Choroidal Neovascularization
1 clinical trials · Condition
◉ Watch Pathological Myopic Choroidal Neovascularization
| Record | Firm | Date |
|---|---|---|
| 601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV) (NCT04922151) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2021-06-04 |
Track Pathological Myopic Choroidal Neovascularization automatically
Every clearance here is in the API, with alerts when new ones post.